TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2025

High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial.

Bjørn Henning Grønberg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.